Hi
@Amused,
To answer some of your questions:
1.) The lab is at Stanford where Laurel is working with Ron. The technology/machine used is specialist, and expensive. Many Universities have this type of equipment, but very few are using it for ME/CFS
2.) Replication is important for many reasons. In this preliminary study, if the findings are replicated, we will have a biomarker for ME/CFS. It needs to be replicated to make sure that the findings were not just isolated to the participants in the study, though I believe this unlikely due to various reasons-replication is mainly for validity and reliability, and to help determine if there are any extraneous variables-an independent study would be useful here. Double checking essentially.
This is very different to XMRV, and the testing is very robust. The chances that the results are due to lab contamination is extremely unlikely (I want to go further than that but wont). This is not the sort of thing that could be contaminated in the same manner as XMRV- we are not testing for viruses directly here, we are testing for metabolites, or metabolic byproducts in the blood. The samples are very sensitive for metabolomics in terms of storage, but it was run by Dr Naviaux and team at UCSD and I have complete faith in him and his methods. It is not comparable in the slightest to the XMRV debacle.
Thankyou so much for your donation. You are helping fund further research with OMF and Prof. Davis and Dr Naviaux, and the entire team
B